Cargando…
Targeting Copper in Cancer Imaging and Therapy: A New Theragnostic Agent
Copper is required for cancer cell proliferation and tumor angiogenesis. Copper-64 radionuclide ((64)Cu), a form of copper chloride ((64)CuCl(2)), is rapidly emerging as a diagnostic PET/CT tracer in oncology. It may also represent an interesting alternative to gallium-68 ((68)Ga) as a radionuclide...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821557/ https://www.ncbi.nlm.nih.gov/pubmed/36615024 http://dx.doi.org/10.3390/jcm12010223 |